Alexandra Tilt, MD
Plastic and Reconstructive Surgery · Virginia Beach, VANPI 1609261924
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (38.9%), travel and lodging and other — rather than concentrated in one kind of arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 22.1%.
Across 115 payments — averaging $113.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- TELA Bio, Inc.$3K
- Integra Lifesciences Corporation$3K
- Musculoskeletal Transplant Foundation Inc.$2K
- RTI Surgical, Inc$1K
- Mentor Worldwide LLC$589
- plus $755 from 11 others
What the payments were for
- Speaking & faculty fees$1,2009%
- Travel & lodging$4,05131%
- Food & beverage$5,07739%
- Other$2,71121%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 34 | $2,888 |
| TELA Bio, Inc. | 14 | $2,772 |
| Integra Lifesciences Corporation | 6 | $2,751 |
| Musculoskeletal Transplant Foundation Inc. | 15 | $1,865 |
| RTI Surgical, Inc | 3 | $1,419 |
| Mentor Worldwide LLC | 12 | $589 |
| Lifenet Health | 12 | $315 |
| Smith+Nephew | 5 | $118 |
| Convatec Inc. | 4 | $95 |
| Davol Inc. | 2 | $52 |
| Organogenesis Inc. | 2 | $38 |
| Kerecis Limited | 1 | $31 |
| Solventum Corporation | 1 | $31 |
| Innovation Technologies Inc | 1 | $21 |
| Galderma Laboratories, L.p. | 1 | $20 |
| Biocomposites Inc | 1 | $19 |
| Motiva USA, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,039 in reported general payments places this provider in the 85th percentile of 77 plastic and reconstructive surgery providers in Virginia.
See all plastic and reconstructive surgery providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 17 | $170 |
| Cefadroxil | 12 | $75 |
| Cephalexin | 11 | $59 |
| Oxycodone Hcl | 13 | $48 |
| Meloxicam | 11 | $10 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Virginia Beach
- Alexander SailonVirginia Beach$19K
- Nicholas GalardiVirginia Beach$8K
- Martin CarneyVirginia Beach$1K
- Maurice NahabedianMc Lean$828K
- Mark VenturiMc Lean$356K
- Neil ZemmelRichmond$38K
- Lauren NigroRichmond$28K
- Burton SundinRichmond$23K
- Vinod ChopraChantilly$19K
- Samita GoyalGlen Allen$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.